# Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma

> **NCT00291538** · PHASE1 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** bortezomib

## Key facts

- **NCT ID:** NCT00291538
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2007-06
- **Final completion:** 2008-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291538, "Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00291538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*